ADA & ACC Consensus Statement Lipoprotein Management in Patients with Cardiometabolic Risk Thomas Dayspring, MD, FACP Clinical Assistant Professor of Medicine.
V. Gerc Clinic for Heart Disease and Rheumatism Sarajevo Advantages of renin-angiotensin system blockade in the treatment of cardiovascular disease.
